Konings Mickey, Siddig Emmanuel, Eadie Kimberly, Minlekib Carole Pab, Faye Maguette, Sow Doudou, Fahal Ahmed, Verbon Annelies, van de Sande Wendy
Erasmus MC, Department of Medical Microbiology and Infectious Diseases, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.
Faculty of Medical Laboratory Sciences, University of Khartoum, Kphartoum, Sudan.
Eur J Clin Microbiol Infect Dis. 2025 Apr 30. doi: 10.1007/s10096-025-05134-4.
Mycetoma is a neglected tropical disease that affects the subcutaneous tissue. The disease can be caused by over 90 different pathogens, including both bacteria (actinomycetoma) and fungi (eumycetoma). While diagnostic tools for eumycetoma causative agents are available, these are generally not well suited for use in endemic regions. This study aims to develop an isothermal based multiplex recombinase polymerase amplification reaction (RPA), that can be integrated in the diagnostic workflow of endemic regions.
The RPA was designed targeting the Internal Transcribed Spacer (ITS) region to detect the presence of fungal DNA, and to differentiate between Madurella mycetomatis and Falciformispora senegalensis. The performance of the RPA was evaluated using 71 fungal isolates and five actinomycetes reference isolates. Furthermore, the limit of detection (LOD) was determined for the different probes in singleplex and multiplex.
The ITS probe was positive for all 71 fungal isolates with a mean detection time of 13.1 min. The M. mycetomatis and F. senegalensis probes were only positive for their respective targets, with a mean detection time of 9.3 and 7.6 min, respectively. No cross-reactivity was detected, and a limit of detection of 0.01 ng of fungal DNA was found. The costs of the RPA ranged from €1.56 to €10.03, depending on the workflow.
We developed a field-friendly multiplex RPA, that successfully detects fungal DNA and discriminates between M. mycetomatis and F. senegalensis. This tool holds promise for enhancing diagnostic capabilities in eumycetoma endemic regions, paving the way for improved patient management and treatment outcomes.
足菌肿是一种影响皮下组织的被忽视的热带病。该疾病可由90多种不同病原体引起,包括细菌(放线菌性足菌肿)和真菌(真菌性足菌肿)。虽然有针对真菌性足菌肿病原体的诊断工具,但这些工具通常不太适合在流行地区使用。本研究旨在开发一种基于等温的多重重组酶聚合酶扩增反应(RPA),可整合到流行地区的诊断流程中。
设计RPA靶向内部转录间隔区(ITS)区域,以检测真菌DNA的存在,并区分马杜拉足菌和塞内加尔镰孢菌。使用71株真菌分离株和5株放线菌参考分离株评估RPA的性能。此外,还确定了单重和多重情况下不同探针的检测限(LOD)。
ITS探针对所有71株真菌分离株均呈阳性,平均检测时间为13.1分钟。马杜拉足菌和塞内加尔镰孢菌探针仅对各自的靶标呈阳性,平均检测时间分别为9.3分钟和7.6分钟。未检测到交叉反应,发现真菌DNA的检测限为0.01 ng。根据工作流程的不同,RPA的成本在1.56欧元至10.03欧元之间。
我们开发了一种对现场友好的多重RPA,它能成功检测真菌DNA,并区分马杜拉足菌和塞内加尔镰孢菌。该工具有望提高真菌性足菌肿流行地区的诊断能力,为改善患者管理和治疗结果铺平道路。